A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Calibr, a division of Scripps Research
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Hackensack Meridian Health
University Hospital, Caen
University Hospital, Caen
National Institutes of Health Clinical Center (CC)
University Hospital, Toulouse
University of Nebraska
Dana-Farber Cancer Institute
University of Chicago
Massachusetts General Hospital
Hoffmann-La Roche
Columbia University
BeOne Medicines
Mayo Clinic
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
BeOne Medicines
Eli Lilly and Company
Prelude Therapeutics
M.D. Anderson Cancer Center
Acerta Pharma BV
Iovance Biotherapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Acerta Pharma BV
Ohio State University Comprehensive Cancer Center
University of California, San Diego
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
Lomond Therapeutics Holdings, Inc.
AbbVie
AstraZeneca
National Cancer Institute (NCI)
French Innovative Leukemia Organisation
AbbVie
BeOne Medicines
Oncology Institute of Southern Switzerland
Hoffmann-La Roche
Thomas Jefferson University
AbbVie
Regeneron Pharmaceuticals
Janssen Research & Development, LLC
Octapharma
UNC Lineberger Comprehensive Cancer Center
University of California, San Diego
Genentech, Inc.